Article Summary
卢宏俐,胡倩倩,何华萍,康俞莉,张 立.他克莫司乳膏联合治疗白癜风的疗效评价[J].现代生物医学进展英文版,2020,(2):273-276.
他克莫司乳膏联合治疗白癜风的疗效评价
Evaluation of the Clinical Efficacy of Combined Treatment with Tacrolimus for Vitiligo
Received:June 06, 2019  Revised:June 30, 2019
DOI:10.13241/j.cnki.pmb.2020.02.014
中文关键词: 白癜风  自体表皮移植术  他克莫司  复色
英文关键词: Vitiligo  Autologous epidermal grafting  Tacrolimus  Repigmentation
基金项目:国家自然科学基金项目(81803159)
Author NameAffiliationE-mail
LU Hong-li 1 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200030, China
2 Department of Nursing, Huashan Hospital, Fudan University, Shanghai, 200030, China
3 Shanghai Institute of Dermatology, Shanghai, 200030, China 
LHL_2018@sohu.com 
HU Qian-qian Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200030, China  
HE Hua-ping Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200030, China  
KANG Yu-li 1 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200030, China
3 Shanghai Institute of Dermatology, Shanghai, 200030, China 
 
ZHANG Li 1 Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, 200030, China
3 Shanghai Institute of Dermatology, Shanghai, 200030, China 
 
Hits: 1173
Download times: 761
中文摘要:
      摘要 目的:通过比较自体表皮移植术联合他克莫司和传统自体表皮移植术治疗白癜风的疗效,明确他克莫司乳膏对白癜风复色率的影响。方法:回顾性分析自体表皮移植术联合他克莫司和传统自体表皮移植术治疗的稳定期白癜风患者共90例,比较其均匀复色时间和疗效。结果:表皮移植术联合他克莫司组起效时间显著性短于单一表皮移植术组(P<0.05),1月、3月的显效率和痊愈率均明显高于单一表皮移植术组(P<0.05)。单一表皮移植术组颈部的疗效相比于头面部、躯干部、四肢更佳(P<0.05),表皮移植术联合0.1%他克莫司软膏外用治疗(相对于单一表皮移植术)可显著性提高位于四肢的皮损的疗效(P<0.05)。相较于单一表皮移植术而言,表皮移植术联合他克莫司对提高节段型和局限型白癜风疗效显著(P<0.05)。然而,他克莫司联合治疗可提高散发型和肢端型白癜风的疗效,但无统计学意义(P>0.05)。表皮移植术联合他克莫司组和单一表皮移植术组中,男性疗效均高于女性,但无显著性差异(P>0.05)。结论:自体表皮移植术联合0.1%他克莫司软膏治疗白癜风的疗效优于单一自体表皮移植术,他克莫司可有效提高白癜风复色。
英文摘要:
      ABSTRACT Objective: To compare the efficacy of autologous epidermal grafting combined with tacrolimus and conventional autologous epidermal grafting for vitiligo. Methods: The repigmentation time and efficacy of autologous epidermal grafting combined with tacrolimus group and traditional autologous epidermal grafting in total 90 stable vitiligo patients were retrospectively studied. Results: The epidermal transplantation combined with tacrolimus group had significantly shorter repigmentation time than the single epidermal graft group (P<0.05). The efficacy in the epidermal grafting combined with tacrolimus showed significantly higher at 1 month and 3 months after treatment than that of the single epidermal graft group (P< 0.05). The efficacy in different sites are varying, of which the neck is the best; the limbs are the worst. The combination therapy of tacrolimus and autologous epidermal grafting can improve the repigmentation at the site of limbs. The efficacy of autologous epidermal grafting combined with tacrolimus was significantly higher in segmental and localized vitiligo compared with those in single autologous epidermal grafting (P<0.05). However, tacrolimus combination therapy can improve the efficacy of sporadic and acral vitiligo with no statistical difference (P>0.05). There was no significant difference in the gender between the two groups (P>0.05). In autologous epidermal grafting group combined with tacrolimus group and the single epidermal graft group, the efficacy in male was higher than that in female with no significant difference. Conclusion: Autologous epidermal grafting combined with tacrolimus is better for repigmentation than conventional autologous epidermal grafting.
View Full Text   View/Add Comment  Download reader
Close